Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2017 Feb 10;98(2):409–418. doi: 10.1016/j.ijrobp.2017.02.002

Figure 3.

Figure 3

Longitudinal PRO-CTCAE trajectories for radiation dermatitis severity (Panel A) and dysphagia severity (Panel B) at successive visits during the clinical trial, showing the distribution of scores at each time point for all arms combined. Each score number reflects ascending severity of PRO-CTCAE severity response criteria (mild, moderate, severe, very severe).